Frederick Financial Consultants’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
AAP
FIB
RA
Frederick Financial Consultants's REVS Position: Q2 2026 in Review
Frederick Financial Consultants reduced its Columbia Research Enhanced Value ETF (REVS) stake by 0.32% in Q2 2026, selling an estimated $2.59K and leaving 26,216 shares worth $824K. The position accounts for 0.35% of the portfolio, ranked #47.
Frederick Financial Consultants first reported a position in REVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $965K in Q4 2024. 37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.
- Frederick Financial Consultants held 26,216 shares of Columbia Research Enhanced Value ETF worth $824K as of Q2 2026.
- Frederick Financial Consultants sold 84 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $2.59K.
- Columbia Research Enhanced Value ETF made up 0.35% of Frederick Financial Consultants's portfolio in Q2 2026, its #47 holding.
- Frederick Financial Consultants first reported a position in Columbia Research Enhanced Value ETF in Q4 2024 and has held it in 7 quarters since.
- Frederick Financial Consultants's Columbia Research Enhanced Value ETF position peaked at $965K in Q4 2024.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.
Based on Frederick Financial Consultants's 13F filing for Q2 2026, filed 14 Aug 2026.